SIR 2025
Interventional Oncology
Scientific Session
Frank Mohn, DO
Postdoctoral Research Fellow
MD Anderson Cancer Center, United States
Koustav Pal, MBBS (he/him/his)
Postdoctoral Research fellow
MD Anderson, United States
Caleb O'Connor, MS
Data Scientist
MD Anderson Cancer Center, United States
Austin Castelo, BS
Associate Systems Analyst
MD Anderson Cancer Center, United States
Alda Tam, MD, FSIR
Professor
MD Anderson Cancer Center, United States
Rahul A. Sheth, MD, FSIR
Associate Professor
MD Anderson, United States
Kristy Brock, Ph.D.
Professor
The University of Texas MD Anderson Cancer Center, United States
To evaluate the efficacy of various deformable image registration (DIR) processes to quantify three-dimensional (3D) minimal ablative margins (MAM) and correlate this MAM with local disease progression after CT-guided cryoablation of colorectal pulmonary metastases (CPM).
Materials and Methods:
A retrospective, single-institution study was conducted on patients with CPM who underwent percutaneous cryoablation (PC) from March 2016 to April 2023. The first group of patients (n=38 patients, 76 tumors) had MAM quantified through manual segmentation of the tumor and ablation zone, performed by two board-certified interventional radiologists. In the second group where the entire lung was imaged, (n=25 patients, 31 tumors) MAM was calculated using a biomechanical model-based algorithm, following AI-driven auto-segmentation of the lungs, tumors, and ablation zones.
Results:
The study included 38 patients, with a total of 76 CPM treated across 63 sessions. Demographic details are presented in table 1. The median follow-up period was 2.75 years (range: 0.8–8.7 years). Primary efficacy at 1 year was 87%. Of the 76 ablated CPM lesions that underwent manual contouring, 56 (74%) had a MAM greater than 0 mm but less than or equal to 5 mm; 15 (20%) had a MAM greater than 5 mm; and 5 (6%) had a MAM of 0 mm. For the biomechanical DIR with internal boundaries, 14 (39%) lesions had a MAM of 0 mm, 20 (56%) had a MAM between 0 and 5 mm, and 2 (6%) had a MAM greater than 5 mm. In univariable Cox-proportional hazards regression, manually contoured 3D MAM (HR 0.04, 95% CI [0.01–0.17], p< 0.001) and freeze duration (HR 0.82, 95% CI [0.69–0.98], p=.025) and MAM calculated using biomechanical DIR with internal boundaries (HR 0.19, 95% CI [0.04–0.96], p=.045) were significantly associated with reduced risk of local tumor progression.
Conclusion:
3D quantification of MAM significantly predicts local tumor progression for predicting LTP for CPM undergoing PC.